Kasan Insight :: Korea IP Law Blog

Korea IP Law and Practice on Patent, Design, Trademark, Copyright, Trade Secrets and Unfair Competition

Showing posts with label obviousness. Show all posts

Showing posts with label obviousness. Show all posts

Menarini’s Priligy (Dapoxetine HCl) Use Patent held Not Valid as being Obvious

Menarini launched Priligy in Korea. Dapoxetine HCl is the active ingredient in Priligy tablets. Korean patent No. 719, 977 covers the brand...

Low Dose Entecavir Formulation in Korean Patent held as being Obvious by the IPT of KIPO

Entecavir is the active ingredient in Baraclude tablets of BMS. The drug has been sold for the treatment of chronic hepatitis B virus infe...

View web version

Powered by Blogger.